{
  "meta": {
    "title": "64_Cell_Cycle_Specific_Cytotoxic_Drugs",
    "url": "https://brainandscalpel.vercel.app/64-cell-cycle-specific-cytotoxic-drugs-6eeb8939.html",
    "scrapedAt": "2025-11-30T12:34:41.859Z"
  },
  "questions": [
    {
      "text": "The Nobel Prize in Physiology or Medicine, 2018 was awarded to James P. Allison and Tasuku Honjo for which of the following discoveries?",
      "choices": [
        {
          "id": 1,
          "text": "Discovery of mechanisms of autophagy"
        },
        {
          "id": 2,
          "text": "Discoveries of molecular mechanisms controlling the circadian rhythm"
        },
        {
          "id": 3,
          "text": "Discovery of cancer therapy by inhibition of negative immune regulation"
        },
        {
          "id": 4,
          "text": "Discovery that mature cells can be reprogrammed to become pluripotent"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The Nobel prize in Physiology or Medicine, 2018 was awarded to James P. Allison and Tasuku Honjo for the&nbsp;discovery of <strong>cancer therapy by inhibition of negative immune regulation.</strong></p>\n<p><strong>Immune checkpoint inhibitors</strong>&nbsp;inhibit proteins that keep immune responses to cancer cells in check. When these proteins are blocked, the brake on the immune system is released and&nbsp;<strong>T cells</strong> are able to <strong>kill</strong> <strong>cancer cells</strong> more <strong>efficiently.</strong></p>\n<p>The&nbsp;Nobel prize 2018 in Physiology or Medicine&nbsp;was awarded to&nbsp;James P. Allison&nbsp;and&nbsp;Tasuku Honjo&nbsp;for their breakthrough work on unleashing the body&rsquo;s immune system to attack cancer, that has led to an entirely new class of these drugs and brought lasting remissions to many patients who had run out of options.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7018",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is a cell-cycle specific agent?",
      "choices": [
        {
          "id": 1,
          "text": "Ifosfamide"
        },
        {
          "id": 2,
          "text": "Melphalan"
        },
        {
          "id": 3,
          "text": "Vinblastine"
        },
        {
          "id": 4,
          "text": "Cyclophosphamide"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Vinblastine </strong>is a<strong> cell cycle-specific</strong> agent and a vinca alkaloid. It arrests mitosis and acts specifically on<strong> M-phase. </strong></p>\n<p>Cyclophosphamide, melphalan, and ifosfamide are nitrogen mustards and are cell-cycle non-specific agents.</p>\n<div class=\"panel-body ng-scope\">\n<p>Cell cycle specific agents:</p>\n<ul>\n<li>Antimetabolites: S phase</li>\n<li>Camptothecin analogs: S Phase</li>\n<li>Taxanes, Vinca alkaloids: M phase</li>\n<li>Epipodophyllotoxin: G1-S phase</li>\n<li>Bleomycin: G2-M phase</li>\n</ul>\n<p>Cell cycle non-specific agents:</p>\n<ul>\n<li>Alkylating agents</li>\n<li>Platinum analogs</li>\n<li>Anthracyclines</li>\n<li>Mitomycin, dactinomycin</li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1217",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is an antimetabolite?",
      "choices": [
        {
          "id": 1,
          "text": "Cyclosporine"
        },
        {
          "id": 2,
          "text": "Methotrexate"
        },
        {
          "id": 3,
          "text": "Etoposide"
        },
        {
          "id": 4,
          "text": "Vinblastine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Methotrexate is an antimetabolite.&nbsp;It is a <strong>folic acid analog</strong> that <strong>inhibits</strong> the enzyme <strong>dihydrofolate reductase (DHFR)</strong>.&nbsp;Methotrexate and its polyglutamate<strong> also inhibit</strong> the enzymes involved in<strong>&nbsp;denovo purine and thymidylate synthesis.</strong></p><hr><h3>Related Pearl: Classification of antineoplastic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd047e306bdc4310be749978ffaf0c5dx1280x1780.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp; &nbsp;Non-cell-cycle specific drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alkylating agents</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nitrogen mustards</p>\n<ul>\n<li>Cyclophosphamide</li>\n<li>Ifosfamide</li>\n<li>Mechlorethamine</li>\n<li>Melphalan</li>\n<li>Chlorambucil</li>\n<li>Bendamustine</li>\n</ul>\n<p>Nitrosoureas</p>\n<ul>\n<li>Carmustine</li>\n<li>Lomustine</li>\n<li>Semustine</li>\n<li>Streptozocin</li>\n</ul>\n<p>Triazines (methylating agents)</p>\n<ul>\n<li>Procarbazine</li>\n<li>Dacarbazine</li>\n<li>Temozolomide</li>\n</ul>\n<p>Ethyleneimines</p>\n<ul>\n<li>Altretamine</li>\n<li>Thio-TEPA</li>\n</ul>\n<p>Alkyl sulfonates</p>\n<ul>\n<li>Busulfan</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Platinum compounds</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cisplatin</li>\n<li>Carboplatin</li>\n<li>Oxaliplatin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-tumor antibiotics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anthracyclines</p>\n<ul>\n<li>Doxorubicin (adriamycin)</li>\n<li>Daunorubicin (rubidomycin)</li>\n<li>Epirubicin</li>\n<li>Valrubicin</li>\n<li>Mitoxantrone</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Actinomycin-D (Dactinomycin)</li>\n<li>Mitomycin-C</li>\n<li>Bleomycin (also a G2-M phase inhibitor)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong> Cell-cycle specific drugs</strong></td>\n</tr>\n<tr>\n<td><strong>S-phase inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Antimetabolites</strong></td>\n</tr>\n<tr>\n<td>Antifolate\n<ul>\n<li>Methotrexate</li>\n<li>Pemetrexed</li>\n<li>Pralatrexate</li>\n<li>Raltitrexed</li>\n</ul>\nPurine analogues\n<ul>\n<li>6-Mercaptopurine</li>\n<li>6-Thioguanine</li>\n<li>Fludarabine</li>\n<li>Cladribine</li>\n<li>Pentostatin</li>\n</ul>\nPyrimidine analogues\n<ul>\n<li>5-Fluorouracil</li>\n<li>Capecitabine</li>\n<li>Gemcitabine</li>\n<li>Cytarabine</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Topoisomerase inhibitors</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase-1 inhibitors (ca)\n<ul>\n<li>Irinotecan</li>\n<li>Topotecan</li>\n</ul>\nTopoisomerase-2 inhibitors\n<ul>\n<li>Etoposide</li>\n<li>Teniposide</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Histone deacetylase inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vorinostat</li>\n<li>Belinostat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&nbsp;Hydroxyurea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>M-phase inhibitors (antimitotics or microtubule damaging agents)</strong></td>\n</tr>\n<tr>\n<td><strong>Vinca alkaloids</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vincristine(Oncovin)</li>\n<li>Vinblastine</li>\n<li>Vinorelbine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Taxanes</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Paclitaxel</li>\n<li>Docetaxel</li>\n<li>Cabazitaxel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epothilones</li>\n<li>Eribulin</li>\n<li>Estramustine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>G1-S phase inhibitor</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epipodophyllotoxin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1151",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following disease-modifying anti rheumatoid drug increases extracellular adenosine?",
      "choices": [
        {
          "id": 1,
          "text": "Methotrexate"
        },
        {
          "id": 2,
          "text": "Lefunamide"
        },
        {
          "id": 3,
          "text": "Sulphasalazine"
        },
        {
          "id": 4,
          "text": "Hydroxychloroquine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Methotrexate</strong> is the disease-modifying anti rheumatoid drug that <strong>increases extracellular adenosine</strong>. Methotrexate&rsquo;s principal mechanism of action relates to inhibition of amino-imidazole carboxamide ribonucleotide (AICAR) transformylase and thymidylate synthetase.</p>\n<p>AICAR accumulates intracellularly, competitively inhibits AMP deaminase, leading to an <strong>accumulation of AMP</strong>.&nbsp;The AMP is released and converted extracellularly to <strong>adenosine, </strong>which is a <strong>potent inhibitor of inflammation</strong>. As a result, the inflammatory functions of neutrophils, macrophages, dendritic cells, and lymphocytes are suppressed.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9f8d4a9516b044e2a3f0355baf01eb5cx1280x1905.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9514",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following conditions is methotrexate not used?",
      "choices": [
        {
          "id": 1,
          "text": "Giant cell arteritis"
        },
        {
          "id": 2,
          "text": "Psoriasis"
        },
        {
          "id": 3,
          "text": "Sickle cell anemia"
        },
        {
          "id": 4,
          "text": "Organ transplantation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Indications for methotrexate (inflammatory conditions) include:</p>\n<ul>\n<li>Rheumatoid arthritis</li>\n<li><strong>Psoriasis&nbsp;</strong></li>\n<li>Psoriatic arthritis</li>\n<li>Ankylosing spondylitis</li>\n<li>Polymyositis</li>\n<li>Dermatomyositis</li>\n<li>Wegener&rsquo;s granulomatosis</li>\n<li><strong>Giant cell arteritis&nbsp;</strong></li>\n<li>Systemic lupus erythematosus</li>\n<li>Other systemic vasculitis</li>\n<li><strong>Graft versus host disease associated with organ transplantation.</strong></li>\n</ul>\n<p>Sickle cell anemia appears to be the most appropriate answer among the options. Though small trials have shown positive results in sickle cell disease, it is neither extensively used nor approved for this indication.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1152",
      "difficulty": "easy"
    },
    {
      "text": "In which of the following conditions is high dose methotrexate indicated in?",
      "choices": [
        {
          "id": 1,
          "text": "Osteosarcoma"
        },
        {
          "id": 2,
          "text": "Rhabdomyosarcoma"
        },
        {
          "id": 3,
          "text": "Retinoblastoma"
        },
        {
          "id": 4,
          "text": "Ewing’s sarcoma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>High-dose methotrexate with leucovorin rescue (HDM-L) is a standard agent for adjuvant therapy of <strong>osteosarcoma</strong>.&nbsp;HDM is critical in the management of childhood acute lymphocytic leukemia (ALL). HDM-L also produces a high response rate in CNS lymphomas.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1153",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old lady was diagnosed with gestational trophoblastic neoplasia and started on methotrexate. However the hCG levels of the patient kept rising. What could be the cause of this phenomenon?",
      "choices": [
        {
          "id": 1,
          "text": "Depletion of folate"
        },
        {
          "id": 2,
          "text": "Overproduction of DHFR"
        },
        {
          "id": 3,
          "text": "Overproduction of thymidylate kinase"
        },
        {
          "id": 4,
          "text": "Decreased DHFR"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The scenario depicts a case of<strong> Methotrexate resistance</strong>. This happens due to the <strong>overproduction of DHFR&nbsp;</strong>(dihydrofolate reductase).</p>\n<p>Mechanism of resistance to methotrexate includes:</p>\n<ul>\n<li>Impaired transport of methotrexate into cells</li>\n<li>Production of altered forms of DHFR that have decreased affinity for methotrexate</li>\n<li>The increased concentration of intracellular DHFR through gene amplification or gene regulation</li>\n<li>Decreased ability to form methotrexate polyglutamates</li>\n<li>Increased expression of drug efflux transporter</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1154",
      "difficulty": "medium"
    },
    {
      "text": "A patient with impaired renal function, undergoing chemotherapy, develops methotrexate toxicity. Which of the following drugs is a methotrexate cleaving enzyme that can be used to manage this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Adenyl cyclase"
        },
        {
          "id": 2,
          "text": "Glucarpidase"
        },
        {
          "id": 3,
          "text": "Rasburicase"
        },
        {
          "id": 4,
          "text": "Serine protease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Glucarpidase</strong>, which is a methotrexate cleaving enzyme, can be used in this condition. Glucarpidase&nbsp;is an FDA approved intravenous drug for the treatment of <strong>methotrexate</strong> <strong>toxicity&nbsp;</strong>in the treatment of cancer patients who have<strong>&nbsp;impaired kidney function.&nbsp;</strong></p>\n<p>Glucarpidase is a recombinant bacterial enzyme that breaks down methotrexate into inactive metabolites rapidly after injection. These inactive metabolites are then eliminated by the liver.</p>\n<p>Note: Leucovorin is also a substrate of glucarpidase. Leucovorin is avoided 2 hours before and after the administration of glucarpidase to avoid its breakdown.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1156",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements about methotrexate is false?",
      "choices": [
        {
          "id": 1,
          "text": "Folinic acid enhances its action"
        },
        {
          "id": 2,
          "text": "It inhibits dihydrofolate reductase"
        },
        {
          "id": 3,
          "text": "Non-proliferative cells are resistant to it"
        },
        {
          "id": 4,
          "text": "It targets the S-phase of the cell cycle"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Folinic acid,&nbsp;</strong>also known as&nbsp;leucovorin, the active form of folic acid,<strong>&nbsp;</strong>is administered <strong>with methotrexate</strong> to <strong>reduce the toxicity</strong> associated with higher doses. It does not enhance the action of methotrexate.</p>\n<p><strong>Methotrexate</strong> is an antimetabolite that <strong>inhibits dihydrofolate reductase</strong>.&nbsp;It is a cell cycle (S-phase) specific antineoplastic agent and non-proliferative cells are relatively resistant to it.&nbsp;</p>\n<p><strong>Bone marrow suppression</strong> and&nbsp;gastrointestinal mucosa inflammation (<strong>mucositis</strong>) are the common <strong>side effects</strong> seen due to inhibition of DNA synthesis.&nbsp;</p>\n<p><strong>Methotrexate toxicity:</strong></p>\n<ul>\n<li><strong>Prevention -</strong>&nbsp;administration of <strong>leucovorin/folinic acid</strong>.</li>\n<li><strong>Treatment -</strong>&nbsp;maintaining<strong> adequate hydration</strong> and <strong>forced alkaline diuresis</strong> in patients with normal renal function.</li>\n<li>Glucarpidase&nbsp;is an intravenous drug administered in patients&nbsp;who have<strong>&nbsp;</strong>impaired renal function.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1158",
      "difficulty": "medium"
    },
    {
      "text": "A patient is on methotrexate therapy as part of his chemotherapy regimen. Which of the following tests is not indicated for monitoring in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Liver function test"
        },
        {
          "id": 2,
          "text": "Lung function test"
        },
        {
          "id": 3,
          "text": "Fundoscopy"
        },
        {
          "id": 4,
          "text": "Hemogram"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Fundoscopy is not monitored in a patient on methotrexate therapy. This is because no significant eye-related adverse effect is associated with either low, normal or high-dose methotrexate use, mandating frequent monitoring.</p>\n<p>Option A - <strong>Hepatic fibrosis</strong> or cirrhosis is a significant side effect of long-term therapy of methotrexate that requires regular hepatic function monitoring.</p>\n<p>Option B - <strong>Allergic interstitial pneumonitis</strong> and other pulmonary-related adverse effects are associated with methotrexate.</p>\n<p>Option D - <strong>Myelosuppression</strong> is a common and a serious adverse effect that mandates routine monitoring of hemogram.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1155",
      "difficulty": "medium"
    },
    {
      "text": "During rounds, one of your colleagues suggested alkalization of urine with sodium bicarbonate for a patient, to reduce the toxicity of a chemotherapeutic agent. Which is the chemotherapeutic drug being discussed here?",
      "choices": [
        {
          "id": 1,
          "text": "Arabinoside-cytosine"
        },
        {
          "id": 2,
          "text": "Ifosfamide"
        },
        {
          "id": 3,
          "text": "Cisplatin"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The drug being discussed here is <strong>methotrexate</strong>. Alkalization of urine ameliorates the toxicity of methotrexate.&nbsp;<strong>Methotrexate</strong> is an acidic drug and the<strong> excretion</strong> is <strong>increased by alkalization of urine</strong>.&nbsp;</p>\n<p>High-dose methotrexate with leucovorin (HDM-L) used in some conditions has a higher incidence of nephrotoxicity. It is attributed to the precipitation of methotrexate in the acidic tubular fluid.&nbsp;Vigorous hydration and alkalinization of urine prior to HDM-L administration is required to minimize the chance of nephrotoxicity.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1157",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is an inhibitor of DNA synthesis?",
      "choices": [
        {
          "id": 1,
          "text": "6-mercaptopurine"
        },
        {
          "id": 2,
          "text": "Mitomycin"
        },
        {
          "id": 3,
          "text": "Actinomycin"
        },
        {
          "id": 4,
          "text": "Asparaginase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>6-Mercaptopurine</strong> is an inhibitor of DNA synthesis.</p>\n<p>6-Mercaptopurine is inactive in its parent form. It must be metabolized by hypoxanthine-guanine&nbsp;phosphoribosyltransferase to form <strong>monophosphate nucleotide 6-thioinosinic acid.</strong> This inhibits several enzymes of de novo purine nucleotide synthesis.</p>\n<p>Option B- <strong>Mitomycin</strong> acts as an <strong>alkylating agent</strong> and crosslinks DNA. It also generates free radicals which damage DNA.</p>\n<p>Option C-<strong> Actinomycin</strong> causes <strong>single-strand breaks in DNA</strong>. It&nbsp;blocks RNA transcription as well.</p>\n<p>Option D-<strong> L-Asparaginase</strong>&nbsp;causes the breakdown of asparagine and thus <strong>interferes with protein synthesis.</strong></p><hr><h3>Related Pearl: Enzymes of Purine Synthesis Pathway and Their Regulators</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Enzymes</strong></p>\n</td>\n<td>\n<p><strong>Regulators</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PRPP Glutamyl Amidotransferase</p>\n</td>\n<td>\n<p>Inhibited by Amp &amp; GMP</p>\n<p>Activator &nbsp;PRPP</p>\n<p>Activated by Glutamine</p>\n<p>Diazanorleucine(inhibitor)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>PRPP synthetase</p>\n</td>\n<td>\n<p>Activator pi</p>\n<p>Inhibitors &nbsp;purine ribonucleotides</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Formyltransferase</p>\n</td>\n<td>\n<p>Methotrexate, Anti-folate drugs</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>VI Synthetase</p>\n</td>\n<td>\n<p>Azaserine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Adenylosuccinase ,IMP Dehydrogenase</p>\n</td>\n<td>\n<p>6-mercaptopurine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>IMP Dehydrogenase</p>\n</td>\n<td>\n<p>mycophenolic acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0782",
      "difficulty": "easy"
    },
    {
      "text": "What should be done to the dose of intravenous 6-mercaptopurine when it is administered in a patient taking allopurinol?",
      "choices": [
        {
          "id": 1,
          "text": "Reduce by 75%"
        },
        {
          "id": 2,
          "text": "Reduce by 50%"
        },
        {
          "id": 3,
          "text": "Increase by 50%"
        },
        {
          "id": 4,
          "text": "No dose adjustment necessary"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Intravenous </strong>dosing of <strong>6-mercaptopurine</strong> (6MP) <strong>does&nbsp;not require</strong> any <strong>dosing adjustment </strong>when administered with allopurinol.&nbsp;</p>\n<p>6MP undergoes the first-pass metabolism by xanthine oxidase in the liver and intestine. Since allopurinol inhibits xanthine oxidase, it causes elevated levels of 6-MP. Hence, the <strong>oral dose of 6MP</strong> needs to be <strong>reduced by 75 % if allopurinol is given</strong>.</p>\n<p>In the case of<strong> intravenous administration</strong>, the dosage need not be changed as it <strong>escapes the first-pass metabolism.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4303",
      "difficulty": "hard"
    },
    {
      "text": "A patient developed the following lesions after 10 days of initiation of chemotherapy. The patient also complains of similar lesions over soles and they are sensitive to touch. Which is the most likely agent to cause this adverse effect?",
      "choices": [
        {
          "id": 1,
          "text": "Cisplatin"
        },
        {
          "id": 2,
          "text": "Vincristine"
        },
        {
          "id": 3,
          "text": "Capecitabine"
        },
        {
          "id": 4,
          "text": "Mitomycin-C"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image depicts classical findings of <strong>hand-foot syndrome</strong> and <strong>capecitabine</strong> is commonly associated with this prominent side effect.</p>\n<p>Hand foot syndrome or palmar-plantar erythrodysesthesia consists of erythema, desquamation, pain and sensitivity to touch of the palms and soles.&nbsp;</p>\n<p>Drugs commonly implicated are:</p>\n<ul>\n<li>Capecitabine</li>\n<li>5-Fluorouracil</li>\n<li>Cytarabine</li>\n<li>Pemetrexed</li>\n<li>Doxorubicin</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9fe119a45cdc49f8adf56e21ec3b07a3.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1202",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following patients is pemetrexed the drug of choice?",
      "choices": [
        {
          "id": 1,
          "text": "A patient with malignant mesothelioma"
        },
        {
          "id": 2,
          "text": "A patient with small cell carcinoma"
        },
        {
          "id": 3,
          "text": "A patient with stage II non-small cell lung carcinoma"
        },
        {
          "id": 4,
          "text": "A patient with inflammatory breast cancer"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pemetrexed</strong> is the drug of choice for the treatment of <strong>malignant</strong>&nbsp;<strong>mesothelioma</strong>. It is an <strong>antifolate</strong> drug that belongs to the antimetabolite group.</p>\n<p>It acts by <strong>inhibiting thymidylate synthase</strong>&nbsp;and<strong> dihydrofolate reductase (DHFR)</strong> and prevents the formation of DNA and RNA, which are required for the growth and survival of both normal cells and cancer cells.</p>\n<p>Pemetrexed is used for the treatment of stage IV non-small cell carcinoma along with cisplatin.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1145",
      "difficulty": "medium"
    },
    {
      "text": "A patient who is undergoing chemotherapy is to be started on allopurinol. Which of these drugs might require dose reduction?",
      "choices": [
        {
          "id": 1,
          "text": "6-mercaptopurine"
        },
        {
          "id": 2,
          "text": "Cyclophosphamide"
        },
        {
          "id": 3,
          "text": "6-thioguanine"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A patient receiving allopurinol requires a dose reduction of&nbsp;<strong>6-mercaptopurine.</strong>&nbsp;</p>\n<p><strong>Allopurinol</strong> is a potent<strong> xanthine oxidase inhibitor</strong> that is often used in acute leukemias as supportive care to prevent the development of hyperuricemia due to tumor lysis syndrome.</p>\n<p><strong>6-mercaptopurine</strong> is converted to an <strong>inactive</strong> metabolite (6-thiouric acid) by <strong>xanthine oxidase</strong> in the liver and intestine.&nbsp;Therefore, the oral bioavailability of the 6-mercaptopurine is reduced significantly due to <strong>high first-pass metabolism.</strong></p>\n<p>Concomitant <strong>allopurinol</strong> use increases<strong> 6-mercaptopurine</strong> availability which leads to <strong>toxicity,</strong> thereby mandating<strong> oral dose reduction.</strong></p>\n<p>Note: Intravenous dosing of 6-mercaptopurine need not require any dosing adjustment when administered with allopurinol.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1160",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following enzymes is inhibited by pentostatin?",
      "choices": [
        {
          "id": 1,
          "text": "Adenosine deaminase"
        },
        {
          "id": 2,
          "text": "Aldolase"
        },
        {
          "id": 3,
          "text": "Adenosine aminase"
        },
        {
          "id": 4,
          "text": "Adenylyl cyclase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Pentostatin <strong>mimics adenosine</strong> and inhibits the enzyme <strong>adenosine deaminase</strong>.&nbsp;Adenosine deaminase inhibition leads to the accumulation of adenosine and deoxyadenosine nucleotides that <strong>blocks&nbsp;DNA synthesis</strong> by inhibiting RNR (ribonucleotide reductase).</p>\n<p>Pentostatin also<strong> inhibits RNA synthesis</strong>, its triphosphate derivative is incorporated into DNA causing strand breakage.&nbsp;</p>\n<p>It is indicated in the treatment of <strong>hairy cell leukemia.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1163",
      "difficulty": "medium"
    },
    {
      "text": "A 50-year-old patient presented with weakness, fatigue, and abdominal discomfort. On examination, splenomegaly was present. Investigations revealed pancytopenia, and his peripheral blood smear is shown below. Immunophenotype testing revealed CD11c, CD25, and CD103 positive. What is the drug of choice for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Pentastatin"
        },
        {
          "id": 2,
          "text": "Cladribine"
        },
        {
          "id": 3,
          "text": "Fludarabine"
        },
        {
          "id": 4,
          "text": "Clofarabine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical scenario, characteristic immunophenotype, and the presence of hairy cells&nbsp;on the Wright-stained peripheral blood smear point to a diagnosis of&nbsp;<strong>hairy cell leukaemia.&nbsp;</strong><strong>Cladribine</strong> is considered the drug of choice for hairy cell leukemia.</p>\n<p>It is administered daily by continuous infusion for <strong>7 days</strong>.&nbsp;A <strong>single course</strong> of therapy achieves a complete response in about 80% of the patients.&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/d3d647ef16074c1594341da1fd62d3af.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4304",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following drugs is a topoisomerase I inhibitor?",
      "choices": [
        {
          "id": 1,
          "text": "Doxorubicin"
        },
        {
          "id": 2,
          "text": "Irinotecan"
        },
        {
          "id": 3,
          "text": "Etoposide"
        },
        {
          "id": 4,
          "text": "Vincristine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Irinotecan</strong> is a topoisomerase I inhibitor.</p>\n<p>Doxorubicin and etoposide inhibit topoisomerase II.</p>\n<p>Vincristine is a vinca alkaloid derivative that inhibits microtubule polymerization.</p><hr><h3>Related Pearl: Classification of antineoplastic drugs</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd047e306bdc4310be749978ffaf0c5dx1280x1780.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>&nbsp; &nbsp;Non-cell-cycle specific drugs</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Alkylating agents</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nitrogen mustards</p>\n<ul>\n<li>Cyclophosphamide</li>\n<li>Ifosfamide</li>\n<li>Mechlorethamine</li>\n<li>Melphalan</li>\n<li>Chlorambucil</li>\n<li>Bendamustine</li>\n</ul>\n<p>Nitrosoureas</p>\n<ul>\n<li>Carmustine</li>\n<li>Lomustine</li>\n<li>Semustine</li>\n<li>Streptozocin</li>\n</ul>\n<p>Triazines (methylating agents)</p>\n<ul>\n<li>Procarbazine</li>\n<li>Dacarbazine</li>\n<li>Temozolomide</li>\n</ul>\n<p>Ethyleneimines</p>\n<ul>\n<li>Altretamine</li>\n<li>Thio-TEPA</li>\n</ul>\n<p>Alkyl sulfonates</p>\n<ul>\n<li>Busulfan</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Platinum compounds</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cisplatin</li>\n<li>Carboplatin</li>\n<li>Oxaliplatin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Anti-tumor antibiotics</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Anthracyclines</p>\n<ul>\n<li>Doxorubicin (adriamycin)</li>\n<li>Daunorubicin (rubidomycin)</li>\n<li>Epirubicin</li>\n<li>Valrubicin</li>\n<li>Mitoxantrone</li>\n</ul>\n<p>Others</p>\n<ul>\n<li>Actinomycin-D (Dactinomycin)</li>\n<li>Mitomycin-C</li>\n<li>Bleomycin (also a G2-M phase inhibitor)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong> Cell-cycle specific drugs</strong></td>\n</tr>\n<tr>\n<td><strong>S-phase inhibitors</strong></td>\n</tr>\n<tr>\n<td><strong>Antimetabolites</strong></td>\n</tr>\n<tr>\n<td>Antifolate\n<ul>\n<li>Methotrexate</li>\n<li>Pemetrexed</li>\n<li>Pralatrexate</li>\n<li>Raltitrexed</li>\n</ul>\nPurine analogues\n<ul>\n<li>6-Mercaptopurine</li>\n<li>6-Thioguanine</li>\n<li>Fludarabine</li>\n<li>Cladribine</li>\n<li>Pentostatin</li>\n</ul>\nPyrimidine analogues\n<ul>\n<li>5-Fluorouracil</li>\n<li>Capecitabine</li>\n<li>Gemcitabine</li>\n<li>Cytarabine</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Topoisomerase inhibitors</strong></td>\n</tr>\n<tr>\n<td>Topoisomerase-1 inhibitors (ca)\n<ul>\n<li>Irinotecan</li>\n<li>Topotecan</li>\n</ul>\nTopoisomerase-2 inhibitors\n<ul>\n<li>Etoposide</li>\n<li>Teniposide</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Histone deacetylase inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vorinostat</li>\n<li>Belinostat</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>&nbsp;Hydroxyurea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>M-phase inhibitors (antimitotics or microtubule damaging agents)</strong></td>\n</tr>\n<tr>\n<td><strong>Vinca alkaloids</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Vincristine(Oncovin)</li>\n<li>Vinblastine</li>\n<li>Vinorelbine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Taxanes</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Paclitaxel</li>\n<li>Docetaxel</li>\n<li>Cabazitaxel</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Others</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epothilones</li>\n<li>Eribulin</li>\n<li>Estramustine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>G1-S phase inhibitor</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Epipodophyllotoxin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1171",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is a mitotic polymerization inhibitor?",
      "choices": [
        {
          "id": 1,
          "text": "Vinblastine"
        },
        {
          "id": 2,
          "text": "Paclitaxel"
        },
        {
          "id": 3,
          "text": "Dactinomycin"
        },
        {
          "id": 4,
          "text": "Gemcitabine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Vinca alkaloids</strong> like vinblastine and vincristine bind to beta-tubulin and <strong>inhibit</strong> its <strong>polymerization</strong> with alpha-tubulin into microtubules.</p>\n<p><strong>Paclitaxel</strong> does not inhibit polymerization, rather it <strong>stabilizes polymerization</strong> and inhibits the breakdown of microtubules.</p>\n<p><strong>Gemcitabine</strong> is an <strong>antimetabolite</strong> and a pyrimidine analog.</p>\n<p><strong>Dactinomycin</strong> or actinomycin D is an <strong>actinomycin.</strong></p><hr><h3>Related Pearl: Microtubule stabilising vs polymerisation inhibiting agents</h3><p>Mnemonic</p>\n<p><strong>Tax</strong>es stabilise economy</p>\n<ul>\n<li><strong>Tax</strong>anes stabilise microtubules</li>\n</ul>\n<p>V<strong>in</strong>ca alklaoids</p>\n<ul>\n<li>Polymerisation <strong>in</strong>hibiting agents</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1173",
      "difficulty": "medium"
    },
    {
      "text": "A patient who was diagnosed with myocardial infarction underwent PCI and stenting with paclitaxel coated drug-eluting stent. What is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Topoisomerase inhibition"
        },
        {
          "id": 2,
          "text": "Increases the polymerisation of tubulin"
        },
        {
          "id": 3,
          "text": "Inhibits protein synthesis"
        },
        {
          "id": 4,
          "text": "Alkylation of DNA"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Paclitaxel binds specifically to beta-tubulin and <strong>promotes</strong> the<strong> polymerization</strong> and inhibits the disassembly of this cytoskeletal protein, resulting in the <strong>arrest </strong>of the cell cycle in<strong> M-phase.</strong></p>\n<p>The first generation drug eluting stents used in PCI were coated with paclitaxel or sirolimus as an anti-proliferative agent. Second-generation drug-eluting stents use newer agents such as everolimus, biolimus, and zotarolimus.</p><hr><h3>Related Pearl: Microtubule stabilising vs polymerisation inhibiting agents</h3><p>Mnemonic</p>\n<p><strong>Tax</strong>es stabilise economy</p>\n<ul>\n<li><strong>Tax</strong>anes stabilise microtubules</li>\n</ul>\n<p>V<strong>in</strong>ca alklaoids</p>\n<ul>\n<li>Polymerisation <strong>in</strong>hibiting agents</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1166",
      "difficulty": "easy"
    },
    {
      "text": "Bone marrow suppression is not seen with which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Vincristine"
        },
        {
          "id": 2,
          "text": "Vinblastine"
        },
        {
          "id": 3,
          "text": "Vinorelbine"
        },
        {
          "id": 4,
          "text": "Methotrexate"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Bone marrow suppression is not seen with<strong> vincristine</strong>.</p>\n<p>Vinblastine and vinorelbine have prominent bone marrow depression.</p>\n<p><strong>Bone marrow sparing</strong> cytotoxic drugs are:</p>\n<ul>\n<li>Vincristine</li>\n<li>Bleomycin</li>\n<li>L-asparaginase</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1211",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man was diagnosed with AML and initiated on chemotherapy. During the course of his treatment, he develops ataxia and slurred speech. Which of the following drugs could have caused this?",
      "choices": [
        {
          "id": 1,
          "text": "Cisplatin"
        },
        {
          "id": 2,
          "text": "Cytarabine"
        },
        {
          "id": 3,
          "text": "Bleomycin"
        },
        {
          "id": 4,
          "text": "Actinomycin D"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This scenario describes a case of <strong>cerebellar toxicity</strong> and <strong>cytarabine</strong> is associated with this condition.</p>\n<p>It is seen especially with <strong>intrathecal</strong> administration or high dose systemic use.&nbsp;Cerebellar toxicity manifests as ataxia and slurred speech.&nbsp;Cerebral toxicity (seizures, dementia, and coma) is also seen.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1192",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is false regarding vincristine?",
      "choices": [
        {
          "id": 1,
          "text": "It is an alkaloid"
        },
        {
          "id": 2,
          "text": "Its use is associated with neurotoxicity"
        },
        {
          "id": 3,
          "text": "It does not cause alopecia"
        },
        {
          "id": 4,
          "text": "It is a useful drug for induction of remission in ALL"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Vincristine </strong>use is associated with<strong> alopecia.</strong>&nbsp;It is usually reversible frequently without discontinuation of the drug.</p>\n<p>Vincristine is a vinca alkaloid derivative.&nbsp;It is mainly indicated for induction of remission in acute leukemias including ALL.&nbsp;Neurotoxicity is one of the main side effects.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1164",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following conditions can all-trans-retinoic acid be used for treatment?",
      "choices": [
        {
          "id": 1,
          "text": "Acute promyelocytic leukemia"
        },
        {
          "id": 2,
          "text": "Acute lymphoblastic leukemia"
        },
        {
          "id": 3,
          "text": "Chronic myelogenous leukemia"
        },
        {
          "id": 4,
          "text": "Chronic lymphocytic leukemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>All-trans-retinoic acid</strong> (tretinoin) is used in the treatment of <strong>acute promyelocytic leukemia</strong> (APL).&nbsp;RAR-alpha and retinoid X receptor dimer binds tretinoin tightly and causes differentiation of promyelocytes resulting in decreased proliferation.&nbsp;</p>\n<p>As monotherapy, tretinoin induces a high rate of complete remission and in combination with anthracyclines cures most of the patients.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1181",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following antineoplastic agents is extracted from the plant shown below?",
      "choices": [
        {
          "id": 1,
          "text": "Epothilones"
        },
        {
          "id": 2,
          "text": "Camptothecin analogs"
        },
        {
          "id": 3,
          "text": "Vinca alkaloids"
        },
        {
          "id": 4,
          "text": "Taxanes"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image shown is of the<strong> periwinkle plant&nbsp;</strong>(<em>Catharanthus roseus)</em>. Vinca alkaloids like vinblastine and vincristine are extracted from this plant.</p>\n<p>Sources&nbsp;of few other drugs are:</p>\n<ul>\n<li>Epothilones - Myxobacterium <em>Sorangium cellulosum</em></li>\n<li>Camptothecin analogs -&nbsp;<em>Camptotheca acuminata&nbsp;</em>tree</li>\n<li>Taxanes - bark of the western yew tree.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8cfcd125db234466ab771d63e1ead398.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4305",
      "difficulty": "easy"
    },
    {
      "text": "A 60-year-old woman is diagnosed with melanoma. On examination, a palpable lymph node was present in the posterior triangle. Biopsy revealed presence of tumour cells. Which of the following drugs used to treat this condition is a MEK inhibitor?",
      "choices": [
        {
          "id": 1,
          "text": "Dabrafenib"
        },
        {
          "id": 2,
          "text": "Vemurafenib"
        },
        {
          "id": 3,
          "text": "Trametinib"
        },
        {
          "id": 4,
          "text": "Ipilimumab"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The scenario is suggestive of <strong>metastatic melanoma</strong> and <strong>trametinib</strong> is used in this condition. It is a <strong>reversible inhibitor</strong> of mitogen-activated extracellular signal regulated kinase (<strong>MEK</strong>). It inhibits the serine-threonine kinase domain of BRAF V600E mutant of MEK.</p>\n<p>It is widely used in the treatment of <strong>metastatic or unresectable melanoma</strong>.<strong>&nbsp;</strong>It can be used as a single agent but it is more effective when used with BRAF inhibitors like dabrafenib.</p>\n<p><strong>Adverse effects</strong> of this drug include rash, diarrhea, increased ALT, abdominal pain, stomatitis, increased AST, anemia, etc.</p>\n<p><strong>Dabrafenib </strong>and <strong>vemurafenib</strong> are <strong>BRAF inhibitors</strong> used in metastatic melanoma.</p>\n<p><strong>Ipilimumab</strong> is a human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used in metastatic or unresectable melanoma.</p><p><strong>Recent update:</strong>&nbsp;The FDA has approved the combination of the <strong>BRAF inhibitor encorafenib </strong>and the<strong> MEK inhibitor binimetinib</strong> for the treatment of patients with<em>&nbsp;</em>BRAF-mutant unresectable or metastatic melanoma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0231",
      "difficulty": "hard"
    },
    {
      "text": "A 55-year-old woman had undergone modified radical mastectomy followed by chemotherapy with trastuzumab. She now presents with liver metastases. Which of the following drugs could be used in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Lapatinib"
        },
        {
          "id": 2,
          "text": "Panitumumab"
        },
        {
          "id": 3,
          "text": "Erlotinib"
        },
        {
          "id": 4,
          "text": "Imatinib"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given scenario depicts a case of <strong>trastuzumab-refractory breast cancer&nbsp;</strong>and <strong>lapatinib</strong> is used in this condition.</p>\n<table>\n<tbody>\n<tr>\n<td>Drug</td>\n<td>Use</td>\n</tr>\n<tr>\n<td>Lapatinib</td>\n<td>Refractory and metastatic breast carcinoma</td>\n</tr>\n<tr>\n<td>Panitumumab</td>\n<td>Colorectal carcinoma</td>\n</tr>\n<tr>\n<td>Erlotinib</td>\n<td>\n<ul>\n<li>Non small cell lung carcinoma</li>\n<li>Pancreatic carcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Imatinib</td>\n<td>\n<ul>\n<li>Chronic myeloid leukemia</li>\n<li>Gastrointestinal stromal tumour</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>In 2018, <strong>Dacomitinib</strong> has been approved by FDA for the treatment of&nbsp;<strong>metastatic non-small-cell lung cancer</strong>. It is a selective and&nbsp;irreversible inhibitor&nbsp;of&nbsp;EGFR.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9441",
      "difficulty": "medium"
    }
  ]
}